Table of contents

Expand All Topics

Trigeminal neuralgia

What's new

The American Academy of Family Physicians (AAFP) has released a rapid evidence review on trigeminal neuralgia. Brain MRI is recommended when trigeminal neuralgia is suspected to rule out alternative causes of symptoms, such as multiple sclerosis or tumors. Carbamazepine is recommended as the first-line treatment. Surgical intervention can be considered for symptom relief in patients with refractory trigeminal neuralgia despite pharmacologic therapy. .

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of trigeminal neuralgia are prepared by our editorial team based on guidelines from the American Academy of Family Physicians (AAFP 2025) and the European Academy of Neurology (EAN 2019).
1
2

Diagnostic investigations

Physical examination: as per EAN 2019 guidelines, do not use clinical characteristics to exclude secondary trigeminal neuralgia.
D
Create free account

More topics in this section

  • MRI

Medical management

General principles
As per EAN 2019 guidelines:
Attempt medical management before offering surgery for trigeminal neuralgia.
B
Treat patients with secondary trigeminal neuralgia similar to patients with primary trigeminal neuralgia.
B

More topics in this section

  • Management of acute exacerbations

  • Long-term management

Nonpharmacologic interventions

Psychological support: as per EAN 2019 guidelines, offer psychological and nursing support to patients with trigeminal neuralgia. Refer to national support groups where these are present.
B

Therapeutic procedures

Botulinum toxin injections: as per EAN 2019 guidelines, consider offering botulinum toxin type A injections as add-on therapy for medium-term treatment in patients with trigeminal neuralgia.
C

Surgical interventions

Surgical interventions: as per AAFP 2025 guidelines, offer surgery for symptom relief in patients who have refractory trigeminal neuralgia pain despite pharmacotherapy.
B